EBOS Group (EBO AU): Synthetic Expert Call Transcript (13 Oct 2026)
Post-Greencross capital allocation has pivoted back to organic optimization and targeted bolt-ons, following the completion of EBOS Group's $360...
51 Views
EBOS (EBO AU): Still Under The Hammer Post Sigma/Chemist Warehouse Merger
Fundamentally, EBOS is sound. The current share price is beaten up. I'd still be getting some exposure here; although it's not a pound-the-table...
88 Views
Top APAC (Ex-China) Investment Worthy Healthcare Companies Using Smartkarma’s Smart Score Screener
We have screened APAC (ex-China) healthcare companies with market cap≥$800M using Smartkarma’s Smart Score and picked up 2 investable ideas by...
635 Views
EBOS Group FY26 Result—A Clear Check-Up
EBOS Group (EBO) reported a robust FY26 result, broadly in line with expectations and guidance across all key line items. First-time FY27 guidance...
93 Views
EBOS Group (EBO): FY26 Result—Initial Impressions
EBOS Group (EBO) reported an in line FY26 result, with underlying EBITDA of A$614m consistent with our A$613m expectations and its revised...
99 Views